Continuing Education Event – Opioid Use Disorders: Trajectory of the Problem and Use of Medications: From Craving management to maintenance to harm reduction – Webinar – 7/28/2020
The opioid epidemic in our country has understandably been given much attention. Here we discuss the prevalence of opiate use/addiction in population, present how the opioid crisis came about in the country, what’s helped address this problem and why this problem isn’t going away.
Medications help substance use disorder patients in varying ways, from significantly decreasing cravings for opioids or alcohol to harm reduction benefits from decreased needle use and HIV/HEP C transmission. There are now 3 primary options for the use of medications in treating substance use disorder: methadone, buprenorphine (Suboxone/Subutex) and naltrexone (VIVITROL®). Although they all provide support in helping our patients, each has different indications, uses, goals, and benefits. In this session, for each medication, we will describe the development, mechanisms of action, intended uses, and “real world” experience implementing these three primary options in medication-assisted treatment. Special focus will be given to their role in diminishing cravings for drugs/alcohol, reducing the harms associated with drug use, and their risk/benefit profile.
• Identify the primary medications used in SUD treatment.
• Describe the purpose and benefit for use of each medication.
• Assess the challenges and activities needed for utilizing medications in SUD treatment.
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 1 credit hour.
Deni Carise, Ph.D.
Chief Scientific Officer
Deni Carise, Ph.D. is a Clinical Psychologist and part of the recovery community for over 30 years. She is currently Chief Scientific Officer of Recovery Centers of America (RCA) and Adjunct Assistant Professor at University of Pennsylvania. RCA is dedicated to creating neighborhood-based treatment and recovery campuses that include detoxification, residential, partial hospital, intensive and traditional outpatient, and family services, all available on one campus. Beginning in March 2016, they opened 6 such campuses, 2 in MA and MD, and 1 each in PA and NJ, multiple outpatient programs and one opioid treatment program. Their goal is to get 1 million Americans into meaningful recovery.
Deni has held similar positions at CRC Health Group, providing behavioral health services to more than 42,000 men, women and teens every day at more than140 programs in 33 states and Phoenix House, a nonprofit substance abuse treatment provider with over 100 programs in 10 states where Dr Carise developed national standards for clinical care, Clinical Toolkits for over 30 evidence-based practices, and helped usher in a new era of care to position the company to successfully address changes secondary to healthcare reform. Dr Carise was also Chief Clinical Advisor for Sierra Tucson, a premier facility treating substance abuse, pain, mood, eating and trauma disorders.